Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implicationsDivij Mathew, Eric Perkey, Sasikanth Manne et al.|Science|2020Cited by 1.7k
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M. Bange, John P. Reilly, Nicholas Han et al.|Nature Medicine|2021Cited by 519
Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventionsDivij Mathew, E. John Wherry, Josephine R. Giles et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 115
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration*Nuala J. Meyer, Steven M. Opal, John P. Reilly et al.|Critical Care Medicine|2017Cited by 98
Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19Charles R. Vasquez, Steven G. Coca, Shruti Gupta et al.|CHEST Journal|2021Cited by 40